229 related articles for article (PubMed ID: 34676991)
41. Impact of Technology-Based Interventions on Patient-Reported Outcomes in Asthma: A Systematic Review.
Doshi H; Hsia B; Shahani J; Mowrey W; Jariwala SP
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2336-2341. PubMed ID: 33548519
[TBL] [Abstract][Full Text] [Related]
42. A cross-sectional study on the application of patient-reported outcome measurements in clinical trials of traditional Chinese medicine in mainland China.
Dong Y; Liu L; Zhang X; Gong Y; Yan S; Li W; Li S; Rong H; Liu J
Front Pharmacol; 2023; 14():1159906. PubMed ID: 37251323
[No Abstract] [Full Text] [Related]
43. Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication.
Yang LY; Manhas DS; Howard AF; Olson RA
Support Care Cancer; 2018 Jan; 26(1):41-60. PubMed ID: 28849277
[TBL] [Abstract][Full Text] [Related]
44. Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019.
Efficace F; Giesinger JM; Cella D; Cottone F; Sparano F; Vignetti M; Aaronson NK
Value Health; 2021 Dec; 24(12):1715-1719. PubMed ID: 34838268
[TBL] [Abstract][Full Text] [Related]
45. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
46. Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.
Safa H; Tamil M; Spiess PE; Manley B; Pow-Sang J; Gilbert SM; Safa F; Gonzalez BD; Oswald LB; Semaan A; Diab A; Chahoud J
J Natl Cancer Inst; 2021 May; 113(5):532-542. PubMed ID: 33146385
[TBL] [Abstract][Full Text] [Related]
47. Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.
Friedlander M; Mercieca-Bebber RL; King MT
Ann Oncol; 2016 Apr; 27 Suppl 1():i66-i71. PubMed ID: 27141076
[TBL] [Abstract][Full Text] [Related]
48. Patient-reported Outcomes (PROs) in clinical trials in paediatric dentistry.
Gilchrist F; Marshman Z
Int J Paediatr Dent; 2020 Dec; 31 Suppl 1():31-37. PubMed ID: 33458920
[TBL] [Abstract][Full Text] [Related]
49. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
50. Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
Holch P; Henry AM; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Albutt A; Velikova G
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):495-510. PubMed ID: 28126299
[TBL] [Abstract][Full Text] [Related]
51. Eliciting adverse effects data from participants in clinical trials.
Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
[TBL] [Abstract][Full Text] [Related]
52. Incorporating patient-reported outcomes in dose-finding clinical trials.
Lee SM; Lu X; Cheng B
Stat Med; 2020 Feb; 39(3):310-325. PubMed ID: 31797421
[TBL] [Abstract][Full Text] [Related]
53. The prognostic significance of patient-reported outcomes in cancer clinical trials.
Gotay CC; Kawamoto CT; Bottomley A; Efficace F
J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
[TBL] [Abstract][Full Text] [Related]
54. A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
Janse van Rensburg HJ; Liu Z; Watson GA; Veitch ZW; Shepshelovich D; Spreafico A; Abdul Razak AR; Bedard PL; Siu LL; Minasian L; Hansen AR
Br J Cancer; 2023 Sep; 129(4):612-619. PubMed ID: 37419999
[TBL] [Abstract][Full Text] [Related]
55. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
[TBL] [Abstract][Full Text] [Related]
56. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.
Perlmutter AS; Tran VT; Dechartres A; Ravaud P
Ann Oncol; 2017 Apr; 28(4):688-695. PubMed ID: 28011448
[TBL] [Abstract][Full Text] [Related]
57. Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies.
Stover AM; Tompkins Stricker C; Hammelef K; Henson S; Carr P; Jansen J; Deal AM; Bennett AV; Basch EM
Med Care; 2019 May; 57 Suppl 5 Suppl 1():S92-S99. PubMed ID: 30985602
[TBL] [Abstract][Full Text] [Related]
58. How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.
LeBlanc MR; Hirschey R; Leak Bryant A; LeBlanc TW; Smith SK
Qual Life Res; 2020 Jun; 29(6):1419-1431. PubMed ID: 31848847
[TBL] [Abstract][Full Text] [Related]
59. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
60. Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.
Giesinger JM; Efficace F; Aaronson N; Calvert M; Kyte D; Cottone F; Cella D; Gamper EM
Value Health; 2021 Apr; 24(4):585-591. PubMed ID: 33840437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
